Bloomfield Hills internal medicine physician Amjad Rass was excited to reunite with family in Syria last month for the first ...
Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.
“The problem with the Alzheimer’s group is they were very co-opted,” said Peter J. Whitehouse, MD, PhD, a professor of ...
In this highly globalised world, competition from foreigners within respective national economies are not only inevitable, ...
Biogen BIIB announced that the FDA has approved a monthly maintenance dosing version for its intravenously (IV) administered ...
By Sriparna Roy (Reuters) -Akero Therapeutics shares gained 106% before the bell on Monday, after its lead drug showed it can help patients with a type of liver disease to reverse scarring of the ...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Eli Lilly & Co (LLY – Research Report), ...
Citi analyst Geoff Meacham maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today. The company’s shares closed last Friday ...